웹BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial. BMC Gastroenterology, Jul … 웹2024년 2월 8일 · This study was funded via the research grant from the National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre. BAT117213 sample collection was funded by GlaxoSmithKline (GSK). This paper presents independent research and the views expressed are those of the authors and not necessarily those of the NIHR or …

Sci-Hub BAT117213: Ileal bile acid transporter (IBAT) inhibition as …

웹DISCUSSION. BAT117213 study is the first randomised controlled crossover trial of ileal bile acid transporter inhibitor, a novel class of drug to treat pruritus in PBC. The main strengths of the trial are utility of a novel, study specific, electronic symptom diary as patient reported outcome to measure the treatment response objectively and the crossover design that … 웹BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: Study protocol for a randomised controlled trial. Hegade V; Kendrick S; Dobbins R; et al. See more; BMC Gastroenterology (2016) 16(1) DOI: 10.1186/s12876-016-0481-9. 23 Citations. Citations of this article. bulls bucks highlights

Linerixibat - an overview ScienceDirect Topics

웹2024년 2월 7일 · BAT117213 was a phase 2a randomised, double-blind, placebo-controlled study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of repeat … 웹Background Pruritus (itch) is a symptom commonly experienced by patients with cholestatic liver diseases such as primary biliary cholangitis (PBC, previously referred to as primary … 웹The secondary outcomes include the evaluation of the effect of GSK2330672 on total serum bile acid (BA) concentrations, serum markers of BA synthesis and steady-state … hairy bikers air fryer review